Home›Companies›Healthcare›Cognito Therapeutics Group

Cognito Therapeutics Group, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 1, 2025·Suggest an edit

About Cognito Therapeutics Group

Cognito Therapeutics Group is a private company based in Cambridge, Massachusetts, incorporated in 2025 in Delaware. It has reported $196,250,015 raised in one offering on Form D since April 2025. Its chief executive is Christian Howell.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 19, 2025Apr 1, 2025$196,250,015fully sold23$8.5MEquity, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Cognito Therapeutics Group's Form D filed Apr 1, 2025.

LB
Laura Brege
Director
RK
Richard Kuntz
Director
Also a director at Elucid.
GC
Gerald Chan
Director
JR
HL
Helen Liang
Director
SB
Stephen Bruso
Director
Also a director at AdaptX, Wellinks and Curve Health.
CH
Christian Howell
Chief Executive Officer and director

Sources

  1. SECCognito Therapeutics Group, Inc. filing history